Effects of Intrauterine Administration of Autologous PBMC Modulated With IFNt on Endometrial Cell Populations

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 13, 2023

Primary Completion Date

March 14, 2026

Study Completion Date

April 28, 2026

Conditions
Infertility
Interventions
BIOLOGICAL

Intrauterine administration of PBMC immunomodulated with IFNt

Standard density gradient centrifugation will be performed to obtain autologous PBMC from patients' peripheral blood (9 ml). Isolated cells will be suspended in RPMI 1640 supplemented with 10% HSA (human serum albumin) and incubated in the presence of 500 IU/ml IFNt for 24 h at 37˚C. The cultured cell suspension will be introduced into the uterine cavity via a catheter.

Trial Locations (1)

1330

RECRUITING

Nadezhda Women's Health Hospital, Sofia

All Listed Sponsors
lead

Nadezhda Women's Health Hospital

OTHER